- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03720756
Effect of a Nickel Free Diet and Nickel Sensitization on GERD Patients.
September 1, 2020 updated by: Zachary Zinn, West Virginia University
There is little evidence on the effect of a nickel-free diet on gastroesophageal reflux disease (GERD).
We hope to determine if a nickel-free diet improves GERD symptoms in patients with a nickel allergy by having patients complete a questionnaire on their GERD symptoms before and after initiation of 8 weeks on a nickel-free diet.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
West Virginia
-
Morgantown, West Virginia, United States, 26501
- WVU Medicine University Town Center
-
Morgantown, West Virginia, United States, 26506
- Physician's Office Center at Ruby Memorial, Digestive Diseases
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- age 18 years or older with a history of GERD
- owns a phone with a camera
- has access to or is willing to sign up for MyChart
- is symptomatic for GERD at time of visit as determined by a score of >12 on the GERD Health Related Quality of Life (GERD-HRQL) questionnaire. (Patients that are currently taking a proton pump inhibitor (PPI) they must have been on the PPI for at least 3 months.)
Exclusion Criteria:
- less than 18 years of age
- no not have access to MyChart
- are not willing to sign up for MyChart
- have taken an oral steroid within 4 weeks
- have experienced a sunburn or had significant sun exposure within the last 4 weeks, or applied a topical steroid to the area that the past test will be applied (i.e. upper back or arm) in the last 4 weeks. No vulnerable populations will be included.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Subjects WITH nickel-sensitivity
Subjects on nickel-free diet who have a positive patch-test result, indicating nickel-sensitivity.
|
Subjects follow a nickel-free diet.
Lists of acceptable foods will be provided to subjects.
|
Active Comparator: Subjects WITHOUT nickel-sensitivity
Subjects on nickel-free diet who have a negative patch-test result, indicating they do NOT have nickel-sensitivity.
|
Subjects follow a nickel-free diet.
Lists of acceptable foods will be provided to subjects.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in baseline Gastroesophageal reflux disease-Health Related Quality of Life (GERD-HRQL) Questionnaire score
Time Frame: after 8 weeks on nickel-free diet
|
questionnaire to assess severity of GERD.
Total Score: Calculated by summing the individual scores to questions 1-12.
Greatest possible score (worst symptoms) = 60; Lowest possible score (no symptoms) = 0.
For the purposes of our study, a score of 13 or above is considered symptomatic for GERD.
|
after 8 weeks on nickel-free diet
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 3, 2019
Primary Completion (Actual)
January 31, 2020
Study Completion (Actual)
February 20, 2020
Study Registration Dates
First Submitted
October 5, 2018
First Submitted That Met QC Criteria
October 24, 2018
First Posted (Actual)
October 25, 2018
Study Record Updates
Last Update Posted (Actual)
September 3, 2020
Last Update Submitted That Met QC Criteria
September 1, 2020
Last Verified
September 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1804080531
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
We do not plan to make IPD available to other researchers.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastroesophageal Reflux
-
GlaxoSmithKlineCompletedReflux, Gastroesophageal | Gastroesophageal Reflux DiseaseAustralia
-
University of North Carolina, Chapel HillNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedGastroesophageal Reflux Disease | GERD | Acid Reflux | RefluxUnited States
-
GlaxoSmithKlineCompletedReflux, Gastroesophageal | Gastroesophageal Reflux DiseaseAustralia
-
TakedaTerminatedGastroesophageal Reflux Disease | Non-erosive Reflux DiseaseSwitzerland, Netherlands
-
Klinikum Garmisch-PatenkirchenNot yet recruitingReflux, Gastroesophageal | Gastro-esophageal RefluxGermany
-
Mansoura UniversityWithdrawnGastroesophageal Reflux Disease
-
Cliniques universitaires Saint-Luc- Université...UnknownGastroesophageal Reflux DiseaseBelgium
-
King Chulalongkorn Memorial HospitalCompleted
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedGastroesophageal Reflux Disease (GERD) | RefluxUnited States, Canada
-
Vanderbilt University Medical CenterCompletedGastroesophageal Reflux Disease (GERD) | Non-erosive Reflux Disease (NERD)United States
Clinical Trials on Nickel-free diet
-
Rush University Medical CenterRecruiting
-
Catholic University of the Sacred HeartCompletedQuality of Life | Systemic Nickel Allergy SyndromeItaly
-
Hospital General Universitario Reina Sofía de MurciaCompletedDiet Modification | Diverticulitis | Dietary Modification | Diverticulitis, Colonic | Acute Diverticulitis | Uncomplicated Diverticular Disease | Diverticulitis of SigmoidSpain
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...UnknownCeliac DiseaseItaly
-
Children's University Hospital, IrelandUniversity College Dublin; Health Research Board, Ireland; Medical Research Charities...Completed
-
University of Roma La SapienzaCompletedCesarean Section ComplicationsItaly
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...Unknown
-
University Hospital, Clermont-FerrandInstitut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement and other collaboratorsRecruitingAnkylosing SpondyloarthritisFrance
-
Universidad de GranadaCompleted
-
University of Southern DenmarkOdense University Hospital; University Hospital Bispebjerg and Frederiksberg; Hospital of Southern Jutland and other collaboratorsNot yet recruitingInflammatory Bowel Diseases | Ulcerative ColitisDenmark